AstraZeneca has selected a candidate to progress in the type 1 diabetes (T1D) Treg cell therapy programme, as per an 18 November press release. It is the first asset licensed by the British big ...
Mozart Therapeutics, the leading developer of CD8 Treg network modulators in autoimmune disease, announces the presentation ...
The alliance is focusing initially on two disease areas – type 1 diabetes and inflammatory bowel disease – and revolves around Quell’s T-regulatory (Treg) cell platform, an area of ...
HCW Biologics gets US FDA nod to begin first-in-human phase 1 trial of HCW9302 to treat patients with moderate-to-severe alopecia areata: Miramar, Florida Wednesday, February 5, 2 ...
Hosted on MSN24d
Immune cells found crucial in preventing pregnancy complicationsResearchers used an advanced mouse model to demonstrate the importance of regulatory T (Treg) cells, a specialized type of anti-inflammatory immune cell, in allowing healthy blood supply to the ...
The goal is to find a cure for alopecia areata, an autoimmune disease that causes hair loss in distinct round patches.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback